Nika Pharmaceuticals Inc.
NIKA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $20 | $1 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $16 | $0 | $0 | $0 |
| Total Curr. Assets | $18 | $20 | $1 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18 | $20 | $1 | $0 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $239 | $102 | $18 | $11 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $239 | $102 | $18 | $11 |
| LT Debt | $0 | $0 | $0 | $14 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $14 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $239 | $102 | $18 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $1 | $1 | $0 |
| Common Stock | $102 | $88 | $88 | $40 |
| Retained Earnings | -$8,928 | -$3,400 | -$3,335 | -$152 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $8,603 | $3,229 | $3,229 | $88 |
| Total Equity | -$221 | -$82 | -$17 | -$24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18 | $20 | $1 | $0 |
| Net Debt | $237 | $82 | $17 | $24 |